According to a study published in JAMA Network Open, among patients with type 2 diabetes (T2D), the use of glucagon-like peptide-1 receptor agonists (GLP-1 RA) was associated with a reduced risk ...

Needless to say, because this is an experimental and unauthorized approach, there are no microdosing guidelines. There is also no reliable information about the safety of this practice, or the ...

Studies show that eating oranges daily, regular exercise, and certain medications can lower depression risk by up to 40%, ...

The global pipeline market is part of the energy sector, influenced by the demand and supply of energy. According to a report ...

Winfrey was photographed by nearby paparazzi as she made her way to her car in the rain. She wore a pair of slate-colored ...

During a Case-Based Roundtable® event, Vamsidhar Velcheti, MD, discussed the TRIDENT-1 trial and practical considerations for ...

Two best friends who took weight loss drugs to lose the extra weight had very different experiences, and now, they've spoken ...

A recent study suggests that GLP-1 receptor agonists (GLP-1RAs) may lower the risk of hematologic cancers, including leukemia ...

An orange a day, regular moderate-to-vigorous exercise, and GLP-1 drugs for diabetes treatment have all been linked to a ...

By screening people for eating disorders and disordered eating before these medications are prescribed, we can prevent ...

We recently published a list of 12 Best Quality Stocks to Invest in Now. In this article, we are going to take a look at ...

SAN DIEGO -- Two retrospective studies hinted at potential negative effects of GLP-1 receptor agonists for patients requiring ...